Anti-PDCD1/PD-1/CD279 Antibody (Nofazinlimab)
Catalog No.
F1330
Anti-PDCD1/PD-1/CD279 Antibody (Nofazinlimab)
Featured Products
Nofazinlimab (CS1003) is a humanIgG4 anti-PD-1 Monoclonal antibody. Nofazinlimab is being investigated for unresectable hepatocellular carcinoma (uHCC).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.08 kDa
Dry ice
2377845-98-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
EQ176, CS-1003, CS1003, CS 1003
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized Human PDCD1 / PD-1 / CD279，His Tag、Mouse PDCD1 / PD-1 / CD279，His Tag、Cynomolgus PDCD1 / PD-1 / CD279，His Tag at 2 ug/mL can bind Anti-PDCD1/PD-1/CD279 Antibody (Nofazinlimab)
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.